Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Adolfo A Ferrando

Showing results (91-100 of 108) with videos related to

Pageof 11
Sort By:
Proceedings of the National Academy of Sciences of the United States of America|January 8, 2017
Activating mutations and translocations in the guanine exchange factor VAV1 in peripheral T-cell lymphomasFrancesco Abate, Ana C da Silva-Almeida, Sakellarios Zairis, et al.
Cancer Cell|December 3, 2013
Direct reversal of glucocorticoid resistance by AKT inhibition in acute lymphoblastic leukemiaErich Piovan, Jiyang Yu, Valeria Tosello, et al.
Blood Cancer Discovery|September 14, 2020
Combinatorial ETS1-dependent control of oncogenic NOTCH1 enhancers in T-cell leukemiaAnna C McCarter, Giusy Della Gatta, Ashley Melnick, et al.
Nature Medicine|December 4, 2019
A selective BCL-X<sub>L</sub> PROTAC degrader achieves safe and potent antitumor activitySajid Khan, Xuan Zhang, Dongwen Lv, et al.
Nature|August 19, 2014
Contrasting roles of histone 3 lysine 27 demethylases in acute lymphoblastic leukaemiaPanagiotis Ntziachristos, Aristotelis Tsirigos, G Grant Welstead, et al.
Nature Genetics|September 6, 2011
Oncogenic IL7R gain-of-function mutations in childhood T-cell acute lymphoblastic leukemiaPriscila P Zenatti, Daniel Ribeiro, Wenqing Li, et al.
Cancer Discovery|January 26, 2022
Targeting S100A9-ALDH1A1-Retinoic Acid Signaling to Suppress Brain Relapse in EGFR-Mutant Lung CancerAnup Kumar Biswas, Seoyoung Han, Yifan Tai, et al.
The Journal of Clinical Investigation|October 31, 2017
Pharmacological inhibition of the transcription factor PU.1 in leukemiaIléana Antony-Debré, Ananya Paul, Joana Leite, et al.
Nature Communications|March 10, 2023
The TINCR ubiquitin-like microprotein is a tumor suppressor in squamous cell carcinomaLucia Morgado-Palacin, Jessie A Brown, Thomas F Martinez, et al.
Blood|October 8, 2015
Tumor-specific HSP90 inhibition as a therapeutic approach in JAK-mutant acute lymphoblastic leukemiasNicole Kucine, Sachie Marubayashi, Neha Bhagwat, et al.
Pageof 11

Showing results (91-100 of 108) with videos related to

Sort By:
Pageof 11
Proceedings of the National Academy of Sciences of the United States of America|January 8, 2017
Activating mutations and translocations in the guanine exchange factor VAV1 in peripheral T-cell lymphomasFrancesco Abate, Ana C da Silva-Almeida, Sakellarios Zairis, et al.
Cancer Cell|December 3, 2013
Direct reversal of glucocorticoid resistance by AKT inhibition in acute lymphoblastic leukemiaErich Piovan, Jiyang Yu, Valeria Tosello, et al.
Blood Cancer Discovery|September 14, 2020
Combinatorial ETS1-dependent control of oncogenic NOTCH1 enhancers in T-cell leukemiaAnna C McCarter, Giusy Della Gatta, Ashley Melnick, et al.
Nature Medicine|December 4, 2019
A selective BCL-X<sub>L</sub> PROTAC degrader achieves safe and potent antitumor activitySajid Khan, Xuan Zhang, Dongwen Lv, et al.
Nature|August 19, 2014
Contrasting roles of histone 3 lysine 27 demethylases in acute lymphoblastic leukaemiaPanagiotis Ntziachristos, Aristotelis Tsirigos, G Grant Welstead, et al.
Nature Genetics|September 6, 2011
Oncogenic IL7R gain-of-function mutations in childhood T-cell acute lymphoblastic leukemiaPriscila P Zenatti, Daniel Ribeiro, Wenqing Li, et al.
Cancer Discovery|January 26, 2022
Targeting S100A9-ALDH1A1-Retinoic Acid Signaling to Suppress Brain Relapse in EGFR-Mutant Lung CancerAnup Kumar Biswas, Seoyoung Han, Yifan Tai, et al.
The Journal of Clinical Investigation|October 31, 2017
Pharmacological inhibition of the transcription factor PU.1 in leukemiaIléana Antony-Debré, Ananya Paul, Joana Leite, et al.
Nature Communications|March 10, 2023
The TINCR ubiquitin-like microprotein is a tumor suppressor in squamous cell carcinomaLucia Morgado-Palacin, Jessie A Brown, Thomas F Martinez, et al.
Blood|October 8, 2015
Tumor-specific HSP90 inhibition as a therapeutic approach in JAK-mutant acute lymphoblastic leukemiasNicole Kucine, Sachie Marubayashi, Neha Bhagwat, et al.
Pageof 11